---
figid: PMC5288206__oncotarget-07-53571-g006
figlink: /pmc/articles/PMC5288206/figure/F6/
number: F6
caption: . Scheme of proposed SLC12A1 antagonist contributes to inhibition of liver
  cancer via the WNK1/ERK5 pathway.
pmcid: PMC5288206
papertitle: Treatment with an SLC12A1 antagonist inhibits tumorigenesis in a subset
  of hepatocellular carcinomas.
reftext: Fei Teng, et al. Oncotarget. 2016 Aug 16;7(33):53571-53582.
pmc_ranked_result_index: '64818'
pathway_score: 0.9585205
filename: oncotarget-07-53571-g006.jpg
figtitle: Treatment with an SLC12A1 antagonist inhibits tumorigenesis in a subset
  of hepatocellular carcinomas
year: '2016'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5288206__oncotarget-07-53571-g006.html
  '@type': Dataset
  description: . Scheme of proposed SLC12A1 antagonist contributes to inhibition of
    liver cancer via the WNK1/ERK5 pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SLC12A1
  - JUN
  - FOS
  - MAPK7
  - CCND1
  - WNK1
  - MYC
  - Bumetanide
genes:
- word: SLC12A1
  symbol: SLC12A1
  source: hgnc_symbol
  hgnc_symbol: SLC12A1
  entrez: '6557'
- word: C-Jun
  symbol: c-Jun
  source: hgnc_alias_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: c-Fos
  symbol: c-fos
  source: hgnc_alias_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: ERK5
  symbol: ERK5
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK7
  entrez: '5598'
- word: CyclinD1
  symbol: Cyclin-D1
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: WNK1
  symbol: WNK1
  source: hgnc_symbol
  hgnc_symbol: WNK1
  entrez: '65125'
- word: c-Myc
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
chemicals:
- word: Bumetanide
  source: MESH
  identifier: D002034
diseases: []
figid_alias: PMC5288206__F6
redirect_from: /figures/PMC5288206__F6
figtype: Figure
---
